AI tools for rheumatology: autoimmune diagnosis, biologic dosing, and CDS

Rheumatology AI is moving toward biologic selection and autoimmune diagnosis support. Here’s the directory. While the promise of AI-driven clinical decision support is immense, many of these advanced tools are still maturing. As practicing clinicians, we can’t afford to wait for the future to optimize our careers. The same mindset we apply to evaluating new biologics—a focus on data, strategy, and long-term outcomes—can be applied to our financial and operational lives today. The strategies are different, but the goal is the same: building a resilient, efficient, and rewarding practice. This article provides a directory of both the emerging clinical AI landscape and the critical, often overlooked, financial strategies that W-2 employed rheumatologists can implement right now. For a broader look at this intersection, see the complete list of rheumatology AI tools and resources.

The AI Frontier: Clinical Decision Support in Rheumatology

The complexity of rheumatology makes it a prime candidate for AI-driven clinical decision support (CDS). The diagnostic journey for many autoimmune diseases is a labyrinth of non-specific symptoms, overlapping serologies, and subtle imaging findings. AI models are being developed to identify patterns in this data that elude human analysis, potentially shortening the diagnostic odyssey for patients with conditions like lupus, Sjögren’s, or undifferentiated connective tissue disease. These tools aim to analyze vast datasets—including EHR data, lab results, and imaging—to flag patients at high risk or suggest differential diagnoses that may not be immediately obvious.

Beyond diagnosis, the next frontier is treatment selection and optimization. With an ever-expanding arsenal of biologics and targeted synthetic DMARDs, choosing the right initial therapy and knowing when to switch can be challenging. AI tools are being designed to predict a patient’s likely response to a specific biologic based on their unique clinical and genetic markers. This could move us from a trial-and-error approach to a more personalized one, improving outcomes and reducing costs associated with ineffective therapies. Similarly, AI could help optimize dosing schedules or predict flares, allowing for proactive management.

The infrastructure for this future is being built now. The technology often takes the form of APIs that can integrate directly into existing EMRs, providing real-time guidance at the point of care. The Pogosh CDS API is an example of this underlying framework, designed to deliver evidence-based clinical logic to developers building next-generation EMR features. As these technologies become more integrated, they will become an indispensable part of our workflow. You can track the progress of these applications in the comprehensive physician AI tools directory.

Understanding the Section 199A Deduction and Its Physician Problem

While we wait for clinical AI to mature, let’s focus on a powerful financial rule you can use now: the Section 199A Qualified Business Income (QBI) deduction. Enacted as part of the Tax Cuts and Jobs Act (TCJA), this rule allows owners of pass-through businesses (like sole proprietorships, S-corps, and partnerships) to deduct up to 20% of their qualified business income. For a physician with $300,000 in pass-through income, this could mean a $60,000 deduction, saving over $20,000 in taxes at a 35% marginal rate.

Here’s the trap for physicians. The law includes a major limitation for any “Specified Service Trade or Business” (SSTB), which explicitly includes “the performance of services in the field of health.” As a physician, your clinical income is SSTB income. This means the 20% deduction begins to phase out and then disappears entirely once your taxable income exceeds certain thresholds. For the 2026 tax year, these thresholds are projected to be approximately $394,000 for single filers and $787,000 for those married filing jointly. Many physicians, even those in non-procedural specialties, can easily exceed these limits, making them completely ineligible for a deduction that other business owners enjoy.

However, for many rheumatologists, particularly those employed by hospital systems or in academic settings, total household income may fall right around this phase-out range. This creates a critical planning opportunity. If your income is just over the threshold, you are leaving tens of thousands of dollars on the table. The key isn’t to earn less, but to strategically manage your Adjusted Gross Income (AGI) to pull it back under the limit and reclaim the full deduction.

Strategic AGI Management to Qualify for the 199A Deduction

If your household income is near or slightly above the Section 199A phase-out threshold, you can use several IRS-sanctioned tools to lower your AGI and qualify for the 20% deduction. This isn’t about hiding income; it’s about maximizing your use of tax-deferred accounts.

Here is the sequence of action:

1. Max Out Pre-Tax Retirement Accounts: This is the first and most powerful lever. For 2026, the employee contribution limit to a 401(k) or 403(b) is projected to be around $24,000. If you are married and your spouse also works, that’s a $48,000 reduction in AGI right off the top. If your plan allows for after-tax contributions that can be converted to a Roth (the “Mega Backdoor Roth”), this won’t lower your AGI but is still a crucial wealth-building step.
2. Utilize a Health Savings Account (HSA): If you are on a high-deductible health plan (HDHP), you are eligible for an HSA. For 2026, the family contribution limit is projected to be $8,750. This contribution is “above-the-line,” meaning it reduces your AGI directly.
3. Consider Charitable Bunching: If you make regular charitable donations, “bunching” them can help. Instead of donating $10,000 each year, you could donate $30,000 every three years into a Donor-Advised Fund (DAF). This large, single-year contribution can help you exceed the standard deduction, allowing you to itemize and further reduce your taxable income in the year you need to get under the 199A threshold.

Let’s run a quick example. A married rheumatologist couple has a combined W-2 income of $850,000. They are above the ~$787,000 MFJ threshold and get no 199A deduction on any side-gig income. By maxing out both of their 403(b)s ($48,000) and an HSA ($8,750), their AGI drops by $56,750. This alone might be enough to get them under the threshold. If they also have a cash balance plan or a Solo 401(k) from a side hustle, the AGI reduction is even more dramatic. The planning trap is ignoring this “on the bubble” scenario. Many physicians assume they are phased out and don’t bother to check if a few strategic moves could save them five figures in taxes.

Rescuing Lost Deductions with 1099 Side Income

One of the most significant blows from the TCJA in 2018 was the elimination of unreimbursed employee expense deductions for W-2 employees. Before this change, you could deduct costs your employer didn’t cover, such as CME, medical licenses, DEA fees, board exam fees, scrubs, and professional society dues. These deductions have been suspended, likely until 2026 or later.

For a typical rheumatologist, these expenses can easily total $5,000 to $10,000 per year. At a 35% marginal tax rate, that’s $1,750 to $3,500 in lost tax savings annually. The solution is surprisingly simple: generate any amount of 1099 independent contractor income. This could come from telemedicine, medical chart review, consulting for a pharma company, or serving as a medical director. Even a few thousand dollars of 1099 income is enough to unlock the strategy.

Here’s how it works. Your 1099 income allows you to file a Schedule C, “Profit or Loss from Business.” This form effectively creates a small business for you on paper. All of those previously non-deductible professional expenses now become legitimate business expenses deductible against your 1099 income on Schedule C. Your CME, state license fees, DEA registration, and journal subscriptions are now ordinary and necessary expenses for your consulting “business.” You can also claim a home office deduction for the portion of your home used exclusively for this work. The result is that your thousands of dollars in professional expenses can wipe out your 1099 income, making it tax-free, and potentially even generate a small loss to offset other income.

Supercharging Retirement with a Solo 401(k)

Once you have established 1099 income, you unlock one of the most powerful retirement savings vehicles available: the Solo 401(k), also known as an Individual 401(k). This is a game-changer for any physician with side-gig income.

A Solo 401(k) allows you to contribute as both the “employee” and the “employer” of your own small business. This dual contribution structure dramatically increases how much you can save on a tax-deferred basis, far beyond a traditional IRA or your W-2 plan’s employee limit.

Here’s the breakdown:

• Employee Contribution: You can contribute up to 100% of your 1099 net income, up to the annual employee limit (projected ~$24,000 for 2026). This is the same limit that applies to your hospital 403(b), but it is a *per-person* limit, not a *per-plan* limit. If you’ve already maxed out your hospital plan, you cannot make another employee contribution here. However, if you haven’t, you can use this space.
• Employer Contribution: As the “employer,” you can contribute an additional 20% of your net self-employment income (your 1099 income minus one-half of your self-employment taxes).

The total combined contributions cannot exceed a set limit (projected to be around $73,000 for 2026). For a rheumatologist earning $50,000 in 1099 income from consulting, they could contribute roughly $10,000 as the “employer” (20% of net) plus their employee contribution, allowing for a massive pre-tax deduction. This directly reduces your AGI, helping you stay under the 199A threshold while aggressively funding your retirement. Many Solo 401(k) plans also allow for Roth contributions and after-tax contributions, enabling the Mega Backdoor Roth strategy on your side income.

The HSA Triple-Stack: Your Best Long-Term Shelter

The Health Savings Account (HSA) is often misunderstood as just a way to pay for current medical bills with pre-tax dollars. For a high-income physician, this is a suboptimal use of its power. The true strategy is to treat the HSA as a supercharged retirement account, leveraging its unique triple tax advantage.

The three advantages are:

1. Tax-Deductible Contributions: The money you put in is tax-deductible, lowering your AGI for the current year. For 2026, the family contribution limit is projected to be $8,750.
2. Tax-Free Growth: Unlike a 401(k) or IRA, the money inside an HSA can be invested in stocks and bonds and grows completely tax-free. There are no capital gains or dividend taxes.
3. Tax-Free Withdrawals: You can withdraw the money at any time, at any age, completely tax-free, as long as it’s used to reimburse yourself for qualified medical expenses.

The key to the “triple-stack” strategy is to never use the HSA to pay for current medical expenses. Instead, pay for all your family’s out-of-pocket medical costs (deductibles, copays, prescriptions, dental, vision) with a credit card or cash. Scan and save every single receipt in a secure digital folder (e.g., Dropbox, Google Drive) labeled by year. Meanwhile, you contribute the maximum to your HSA every year and invest it aggressively in low-cost index funds, just like you would in a 401(k).

Decades later, when you retire, you will have a large, tax-free investment account and a digital folder full of tens or even hundreds of thousands of dollars in accumulated medical receipts. You can then withdraw money from the HSA tax-free by “reimbursing” yourself for those expenses you paid out-of-pocket over the last 20-30 years. It becomes a tax-free emergency fund or a source of tax-free retirement income. It is the only investment vehicle that offers a tax deduction on the way in, tax-free growth, and tax-free distributions, making it superior to even a Roth IRA.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026